메뉴 건너뛰기




Volumn 12, Issue 3, 2012, Pages 630-639

Three-year outcomes from BENEFIT-EXT: A phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys

(18)  Pestana, J O M a   Grinyo, J M b   Vanrenterghem, Y c   Becker, T d,q   Campistol, J M e   Florman, S f   Garcia, V D g   Kamar, N h   Lang, P i   Manfro, R C j   Massari, P k   Rial, M D C l   Schnitzler, M A m   Vitko, S n   Duan, T o   Block, A o   Harler, M B o   Durrbach, A p  


Author keywords

Belatacept; cyclosporine; extended criteria donor; kidney; renal function

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BASILIXIMAB; BELATACEPT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

EID: 84857646161     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03914.x     Document Type: Article
Times cited : (208)

References (34)
  • 1
    • 36649035320 scopus 로고    scopus 로고
    • Renal transplantation from extended criteria cadaveric donors: Problems and perspectives overview
    • DOI 10.1111/j.1432-2277.2007.00543.x
    • Audard V, Matignon M, Dahan K, Lang P, Grimbert P,. Renal transplantation from extended criteria cadaveric donors: Problems and perspectives overview. Transpl Int 2008; 21: 11-17. (Pubitemid 350198281)
    • (2008) Transplant International , vol.21 , Issue.1 , pp. 11-17
    • Audard, V.1    Matignon, M.2    Dahan, K.3    Lang, P.4    Grimbert, P.5
  • 2
    • 65549142166 scopus 로고    scopus 로고
    • Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005
    • Collins MG, Chang SH, Russ GR, McDonald SP,. Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005. Transplantation 2009; 87: 1201-1209.
    • (2009) Transplantation , vol.87 , pp. 1201-1209
    • Collins, M.G.1    Chang, S.H.2    Russ, G.R.3    McDonald, S.P.4
  • 8
    • 0021690115 scopus 로고
    • Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: Beneficial effect of low doses in early post-transplantation period
    • Klintmalm G, Bohman SO, Sundelin B, Wilczek H,. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: Beneficial effect of low doses in early post-transplantation period. Lancet 1984; 2: 950-954.
    • (1984) Lancet , vol.2 , pp. 950-954
    • Klintmalm, G.1    Bohman, S.O.2    Sundelin, B.3    Wilczek, H.4
  • 11
    • 77954623148 scopus 로고    scopus 로고
    • Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure
    • Gaston RS, Cecka JM, Kasiske BL, et al,. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68-74.
    • (2010) Transplantation , vol.90 , pp. 68-74
    • Gaston, R.S.1    Cecka, J.M.2    Kasiske, B.L.3
  • 12
    • 0036820323 scopus 로고    scopus 로고
    • Cardiovascular toxicities of immunosuppressive agents
    • DOI 10.1034/j.1600-6143.2002.20902.x
    • Miller LW,. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002; 2: 807-818. (Pubitemid 36306835)
    • (2002) American Journal of Transplantation , vol.2 , Issue.9 , pp. 807-818
    • Miller, L.W.1
  • 13
    • 10844292763 scopus 로고    scopus 로고
    • Immunosuppressive drugs for kidney transplantation
    • DOI 10.1056/NEJMra033540
    • Halloran PF,. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715-2729. (Pubitemid 39665325)
    • (2004) New England Journal of Medicine , vol.351 , Issue.26 , pp. 2715-2729
    • Halloran, P.F.1
  • 14
    • 0036314948 scopus 로고    scopus 로고
    • Post-transplant renal function in the first year predicts long-term kidney transplant survival
    • DOI 10.1046/j.1523-1755.2002.00424.x
    • Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP,. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311-318. (Pubitemid 34754077)
    • (2002) Kidney International , vol.62 , Issue.1 , pp. 311-318
    • Hariharan, S.1    McBride, M.A.2    Cherikh, W.S.3    Tolleris, C.B.4    Bresnahan, B.A.5    Johnson, C.P.6
  • 15
    • 1442338509 scopus 로고    scopus 로고
    • Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates over the Most Recent Era
    • DOI 10.1111/j.1600-6143.2004.00332.x
    • Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B,. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383. (Pubitemid 38282293)
    • (2004) American Journal of Transplantation , vol.4 , Issue.3 , pp. 378-383
    • Meier-Kriesche, H.-U.1    Schold, J.D.2    Srinivas, T.R.3    Kaplan, B.4
  • 16
    • 34547957878 scopus 로고    scopus 로고
    • Renal transplantation in high-risk patients
    • DOI 10.2165/00003495-200767110-00005
    • Weimert NA, Alloway RR,. Renal transplantation in high-risk patients. Drugs 2007; 67: 1603-1627. (Pubitemid 47267299)
    • (2007) Drugs , vol.67 , Issue.11 , pp. 1603-1627
    • Weimert, N.A.1    Alloway, R.R.2
  • 18
    • 76949090842 scopus 로고    scopus 로고
    • A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)
    • Durrbach A, Pestana JM, Pearson T, et al,. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant 2010; 10: 547-557.
    • (2010) Am J Transplant , vol.10 , pp. 547-557
    • Durrbach, A.1    Pestana, J.M.2    Pearson, T.3
  • 19
    • 78650831358 scopus 로고    scopus 로고
    • Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies
    • Larsen CP, Grinyo J, Medina-Pestana J, et al,. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation 2010; 90: 1528-1535.
    • (2010) Transplantation , vol.90 , pp. 1528-1535
    • Larsen, C.P.1    Grinyo, J.2    Medina-Pestana, J.3
  • 20
    • 76949101581 scopus 로고    scopus 로고
    • A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)
    • Vincenti F, Charpentier B, Vanrenterghem Y, et al,. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010; 10: 535-546.
    • (2010) Am J Transplant , vol.10 , pp. 535-546
    • Vincenti, F.1    Charpentier, B.2    Vanrenterghem, Y.3
  • 21
    • 78650818523 scopus 로고    scopus 로고
    • An integrated safety profile analysis of belatacept in kidney transplant recipients
    • Grinyo J, Charpentier B, Pestana JM, et al,. An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation 2010; 90: 1521-1527.
    • (2010) Transplantation , vol.90 , pp. 1521-1527
    • Grinyo, J.1    Charpentier, B.2    Pestana, J.M.3
  • 22
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
    • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
    • (1999) Annals of Internal Medicine , vol.130 , Issue.6 , pp. 461-470
    • Levey, A.S.1    Bosch, J.P.2    Lewis, J.B.3    Greene, T.4    Rogers, N.5    Roth, D.6
  • 23
    • 34147205677 scopus 로고    scopus 로고
    • Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values
    • DOI 10.1373/clinchem.2006.077180
    • Levey AS, Coresh J, Greene T, et al,. Expressing the modification of diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-772. (Pubitemid 46580250)
    • (2007) Clinical Chemistry , vol.53 , Issue.4 , pp. 766-772
    • Levey, A.S.1    Coresh, J.2    Greene, T.3    Marsh, J.4    Stevens, L.A.5    Kusek, J.W.6    Van Lente, F.7
  • 24
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-266.
    • (2002) Am J Kidney Dis , vol.39 , Issue.SUPPL. 1
  • 26
    • 77956528156 scopus 로고    scopus 로고
    • Five-year safety and efficacy of belatacept in renal transplantation
    • Vincenti F, Blancho G, Durrbach A, et al,. Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol 2010; 21: 1587-1596.
    • (2010) J Am Soc Nephrol , vol.21 , pp. 1587-1596
    • Vincenti, F.1    Blancho, G.2    Durrbach, A.3
  • 27
    • 84857658225 scopus 로고    scopus 로고
    • Application of a validated long-term renal transplant graft survival prediction model to expected belatacept phase III trial outcomes
    • Schnitzler MA, Trivedi D, L'Italien GJ,. Application of a validated long-term renal transplant graft survival prediction model to expected belatacept phase III trial outcomes. Transplantation 2010; 90 (Suppl 2S): 341.
    • (2010) Transplantation , vol.90 , Issue.SUPPL. 2 , pp. 341
    • Schnitzler, M.A.1    Trivedi, D.2    L'Italien, G.J.3
  • 28
    • 84855973130 scopus 로고    scopus 로고
    • Expected median graft survival prediction for belatacept Phase III trial outcomes in kidney transplantation
    • Schnitzler MA, Kalsekar A, You M, L'Italien G,. Expected median graft survival prediction for belatacept Phase III trial outcomes in kidney transplantation. Am J Transplant 2011; 11 (S2): 353-354.
    • (2011) Am J Transplant , vol.11 , Issue.S2 , pp. 353-354
    • Schnitzler, M.A.1    Kalsekar, A.2    You, M.3    L'Italien, G.4
  • 30
    • 0346752037 scopus 로고    scopus 로고
    • Poor Predictive Value of Serum Creatinine for Renal Allograft Loss
    • DOI 10.1046/j.1600-6135.2003.00275.x
    • Kaplan B, Schold J, Meier-Kriesche HU,. Poor predictive value of serum creatinine for renal allograft loss. Am J Transplant 2003; 3: 1560-1565. (Pubitemid 37541513)
    • (2003) American Journal of Transplantation , vol.3 , Issue.12 , pp. 1560-1565
    • Kaplan, B.1    Schold, J.2    Meier-Kriesche, H.-U.3
  • 31
    • 79951771805 scopus 로고    scopus 로고
    • On behalf of the patient outcomes in renal transplantation (PORT) investigators. The relationship between kidney function and long-term graft survival after kidney transplant
    • Kasiske BL, Israni AK, Snyder JJ, Skeans MA,. On behalf of the patient outcomes in renal transplantation (PORT) investigators. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis 2011; 57: 466-475.
    • (2011) Am J Kidney Dis , vol.57 , pp. 466-475
    • Kasiske, B.L.1    Israni, A.K.2    Snyder, J.J.3    Skeans, M.A.4
  • 32
    • 79958717951 scopus 로고    scopus 로고
    • Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs
    • Schnitzler MA, Johnston K, Axelrod D, Gheorghian A, Lentine KL,. Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation 2011; 91: 1347-1356.
    • (2011) Transplantation , vol.91 , pp. 1347-1356
    • Schnitzler, M.A.1    Johnston, K.2    Axelrod, D.3    Gheorghian, A.4    Lentine, K.L.5
  • 33
    • 77958086781 scopus 로고    scopus 로고
    • Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: A cohort study
    • Summers DM, Johnson RJ, Allen J, et al,. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: A cohort study. Lancet 2010; 376: 1303-1311.
    • (2010) Lancet , vol.376 , pp. 1303-1311
    • Summers, D.M.1    Johnson, R.J.2    Allen, J.3
  • 34
    • 49749140379 scopus 로고    scopus 로고
    • A systematic review of kidney transplantation from expanded criteria donors
    • Pascual J, Zamora J, Pirsch JD,. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis 2008; 52: 553-586.
    • (2008) Am J Kidney Dis , vol.52 , pp. 553-586
    • Pascual, J.1    Zamora, J.2    Pirsch, J.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.